# Primrose Bio, Inc. — Form D

Primrose Bio, Inc. of SAN DIEGO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2024-07-17. The offering totals $23.0M, of which $15.0M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2024-07-17
- Form: D
- Accession: 0000929638-24-002501
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $23.0M
- Amount sold: $15.0M
- Remaining: $8.0M
- Investors: 2
- Date of first sale: 2024-06-17
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-518981

## Issuer

- Name: Primrose Bio, Inc.
- CIK: 0002030669
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2023
- Address: 10790 ROSELLE STREET, SAN DIEGO, CA, 92121
- Phone: 1-858-352-4400

## Officers, directors & promoters (6)

| Name | Role | Location |
| --- | --- | --- |
| Wes Todd Kaupinen | Director | San Diego, CA |
| Matthew Todd Korenberg | Director | San Diego, CA |
| J. Todd Mitchell | Director | San Diego, CA |
| Matthew Reber | Director | Chesterfield, MO |
| Helge Zieler | Director | San Diego, CA |
| Helge Zieler | Executive Officer | San Diego, CA |

## More

- [CIK 2030669 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2030669&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0000929638-24-002501.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.